Swati Rao, MD
Clinical Cardiac Electrophysiology · Charleston, SCNPI 1598151805
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (51.7%), food and beverage and grants — rather than concentrated in one kind of arrangement. 30 manufacturers reported payments, led by Biotronik Inc. at 42.3% of the total. Reporting peaked in 2022 at $28,710 and has fallen 82.2% since, to $5,104 in 2025.
Across 416 payments — averaging $145.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biotronik Inc.$26K
- Boston Scientific$16K
- Medtronic$11K
- Abbott$3K
- Medical Device Business Services, Inc.$1K
- Biosense Webster, Inc.$1K
- plus $2K from 24 others
What the payments were for
- Consulting fees$9382%
- Grants$10,00016%
- Travel & lodging$31,38252%
- Food & beverage$17,48929%
- Education$8721%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biotronik Inc. | 104 | $25,682 |
| Boston Scientific | 36 | $16,433 |
| Medtronic | 114 | $10,631 |
| Abbott | 41 | $3,151 |
| Medical Device Business Services, Inc. | 3 | $1,359 |
| Biosense Webster, Inc. | 38 | $1,268 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 12 | $258 |
| Johnson & Johnson | 14 | $251 |
| Cvrx, Inc. | 1 | $171 |
| Pfizer | 8 | $164 |
| Amgen | 7 | $163 |
| Baxter Healthcare | 1 | $149 |
| Janssen Scientific Affairs, LLC | 1 | $149 |
| Novartis | 5 | $95 |
| Philips North America LLC | 4 | $93 |
| Sanofi-aventis U.S. LLC | 1 | $86 |
| Elutia, Inc. | 3 | $84 |
| Acist Medical Systems, Inc. | 3 | $64 |
| E.r. Squibb & Sons, L.L.C. | 3 | $62 |
| Cardiva Medical, Inc. | 1 | $57 |
| Lantheus Medical Imaging, Inc. | 3 | $50 |
| Novo Nordisk | 2 | $45 |
| Kestra Medical Technology Services, Inc. | 2 | $45 |
| AstraZeneca | 3 | $37 |
| Actelion Pharmaceuticals US, Inc. | 1 | $29 |
| Atricure, Inc. | 1 | $28 |
| Esperion Therapeutics, Inc. | 1 | $25 |
| Artivion, Inc. | 1 | $21 |
| Regeneron Healthcare Solutions, Inc. | 1 | $15 |
| Stryker | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BioMonitor$15,294
- Solia$15,161
- Acticor 7 VR-T DX$14,413
- Rivacor 7 DR-T$14,274
- Edora 8 DR-T$14,274
- EMBLEM$5,000
- EMBLEM MRI S-ICD$5,000
- Rivacor$1,895
- Acticor$1,895
- Edora$1,895
- Carto 3$1,635
- Ensite Cardiac Mapping System$1,379
- Sentus$1,346
- Micra$1,296
- Farapulse$938
- Plexa$568
- ACCOLADE$269
- ARCTIC FRONT ADVANCE$259
- GENERAL - THERAPIES$245
- Barostim Neo System$171
How this compares
$60,681 in reported general payments places this provider in the 65th percentile of 58 clinical cardiac electrophysiology providers in South Carolina.
See all clinical cardiac electrophysiology providers in South Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 15 | $12,938 |
| Metoprolol Succinate | 29 | $217 |
| Carvedilol | 12 | $50 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $164 | $12,93815 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 58 clinical cardiac electrophysiology providers in South Carolina.
Other clinical cardiac electrophysiology in Charleston
- Jeffrey WinterfieldCharleston$498K
- Frank CuocoCharleston$306K
- Anne KromanCharleston$279K
- Michael GoldCharleston$204K
- Rachel KaplanCharleston$93K
- Joshua PayneCharleston$81K
- John WhartonCharleston$44K
- Nicole CainCharleston$6K
- Lanier JacksonCharleston$4K
- Rory DowdCharleston$98
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.